Journal of Enzyme Inhibition and Medicinal Chemistry (Dec 2022)

Bat coronaviruses related to SARS-CoV-2: what about their 3CL proteases (MPro)?

  • Matteo Pavan,
  • Davide Bassani,
  • Mattia Sturlese,
  • Stefano Moro

DOI
https://doi.org/10.1080/14756366.2022.2062336
Journal volume & issue
Vol. 37, no. 1
pp. 1077 – 1082

Abstract

Read online

Despite a huge effort by the scientific community to determine the animal reservoir of SARS-CoV-2, which led to the identification of several SARS-CoV-2-related viruses both in bats and in pangolins, the origin of SARS-CoV-2 is still not clear. Recently, Temmam et al. reported the discovery of bat coronaviruses with a high degree of genome similarity with SARS-CoV-2, especially concerning the RBDs of the S protein, which mediates the capability of such viruses to enter and therefore infect human cells through a hACE2-dependent pathway. These viruses, especially the one named BANAL-236, showed a higher affinity for the hACE2 compared to the original strain of SARS-CoV-2. In the present work, we analyse the similarities and differences between the 3CL protease (main protease, Mpro) of these newly reported viruses and SARS-CoV-2, discussing their relevance relative to the efficacy of existing therapeutic approaches against COVID-19, particularly concerning the recently approved orally available Paxlovid, and the development of future ones.

Keywords